2024 annual financial data
Emergent BioSolutions 2024 Operating margin
Emergent BioSolutions 2024 operating margin with verified reported values.
Direct answer
Operating margin was -10.42%.
Operating income was -108,700,000 USD and net income was -190,600,000 USD.
Operating cash flow was 58,700,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,043,599,999 USD
- Operating income
- -108,700,000 USD
- Net income
- -190,600,000 USD
- Operating cash flow
- 58,700,000 USD